Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Current Leases (2019 - 2025)

Quantum Biopharma's Current Leases history spans 7 years, with the latest figure at $103165.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 91.83% to $103165.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $103165.0, a 91.83% increase, with the full-year FY2025 number at $103165.0, up 91.83% from a year prior.
  • Current Leases hit $103165.0 in Q4 2025 for Quantum Biopharma, down from $151798.0 in the prior quarter.
  • Over the last five years, Current Leases for QNTM hit a ceiling of $198273.0 in Q3 2022 and a floor of $9634.0 in Q2 2024.
  • Historically, Current Leases has averaged $105310.2 across 5 years, with a median of $105183.5 in 2023.
  • Biggest five-year swings in Current Leases: crashed 91.01% in 2024 and later surged 1525.2% in 2025.
  • Tracing QNTM's Current Leases over 5 years: stood at $124311.0 in 2021, then soared by 43.08% to $177870.0 in 2022, then plummeted by 64.97% to $62308.0 in 2023, then decreased by 13.69% to $53780.0 in 2024, then skyrocketed by 91.83% to $103165.0 in 2025.
  • Business Quant data shows Current Leases for QNTM at $103165.0 in Q4 2025, $151798.0 in Q3 2025, and $156572.0 in Q2 2025.